Perspectives from the RECIST committee on what constitutes a good tumor response metric

Date 04 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Beyond RECIST: Novel approaches for evaluating tumor response to molecular targeted agents
Topics Cytotoxic agents
Therapy
Biological therapy
Presenter Jan Bogaerts